JAK Inhibitors in the Evolving Treatment Landscape of Atopic Dermatitis

home / peer-exchange / jak-inhibitors-in-the-evolving-treatment-landscape-of-atopic-dermatitis

Expert dermatologists discuss the use of Janus kinase (JAK) inhibitors for the treatment of atopic dermatitis (AD). They review the nuances of currently approved JAK inhibitors, share treatment considerations for AD, and discuss utilizing JAK inhibitors in clinical practice.

© 2024 MJH Life Sciences

All rights reserved.